DIEGO ENRICO | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. DIEGO ENRICO | Medicine and Dentistry | Best Researcher Award

MD at Instituto Alexander Fleming, Argentina

Dr. Diego H. Enrico is an accomplished Medical Oncologist at the Alexander Fleming Cancer Institute in Buenos Aires, Argentina. He specializes in thoracic oncology and is the Coordinator of the Cancer Research and Innovation Unit. Dr. Enrico holds an MD from the University of Morón and completed his oncology residency at Eva Perón General Hospital. He further honed his expertise through a fellowship at the Gustave Roussy Cancer Center in Paris, focusing on translational and clinical cancer research. His research contributions include multiple clinical trials and numerous awards for his work in oncology, particularly in lung and prostate cancer. Dr. Enrico has co-authored several influential studies and received prestigious grants for cancer research. In addition to his clinical and research roles, he is an experienced educator and has served as co-director of research methodology programs. His ongoing work focuses on innovative cancer therapies and improving patient outcomes.

Profile:

Education

Dr. Diego H. Enrico holds a robust academic background in both medicine and business. He earned a Bachelor’s degree in Business Administration from N° 7 Educational School in Luján, Buenos Aires, graduating Summa Cum Laude in 2002 with an impressive 9.9/10 GPA. Pursuing his passion for healthcare, Dr. Enrico then attended the University of Morón School of Medicine, where he completed his MD degree in 2013, graduating Cum Laude with a GPA of 8.89/10. He further specialized in Medical Oncology through a postgraduate degree from the University of Buenos Aires between 2013 and 2015. Dr. Enrico has enhanced his expertise in clinical oncology with advanced studies abroad, completing the European University Diploma in Translational and Clinical Cancer Research and the University Diploma of Clinical Oncology at Université Paris XI, France, in 2019. His international training underscores his dedication to improving cancer research and patient care.

Professional Experiences 

Dr. Diego H. Enrico is a distinguished Medical Oncologist at the Alexander Fleming Cancer Institute in Buenos Aires, Argentina. Since June 2021, he has been an integral part of the Thoracic Oncology Unit, and in June 2022, he also joined the Clinical Research Unit. Dr. Enrico serves as the Coordinator of the Cancer Research and Innovation Unit (ETIC), a role he has held since March 2021. He has extensive experience in both clinical practice and research, specializing in thoracic oncology and leading innovative cancer research projects. Dr. Enrico has also contributed significantly to clinical trials, serving as a sub-investigator in multiple studies focusing on novel treatments for non-small cell lung cancer. His career is further highlighted by his previous fellowship at the prestigious Gustave Roussy Cancer Center in Paris, France, where he worked on translational and clinical research, particularly in thoracic oncology and drug development.

Research Interests

Dr. Diego H. Enrico’s research interests are centered around clinical oncology, with a particular focus on thoracic oncology and innovative cancer treatments. His work delves into the development of targeted therapies for non-small cell lung cancer (NSCLC), emphasizing the genetic and molecular underpinnings of the disease, such as EGFR mutations and KRAS mutations. Dr. Enrico actively participates in clinical trials, contributing to the advancement of combination therapies and immunotherapy strategies, including the use of novel agents like amivantamab, nivolumab, and pembrolizumab. He is also dedicated to improving patient outcomes through translational research, bridging the gap between laboratory findings and clinical applications. Additionally, Dr. Enrico’s interests include investigating biomarkers for cancer prognosis and the evaluation of treatment responses, as well as optimizing the safety and efficacy of cancer therapies through remote monitoring systems and real-life studies in oncology. His contributions significantly impact the field of precision medicine and personalized cancer care.

Research Skills

Dr. Diego H. Enrico possesses a broad range of research skills, particularly in the field of clinical oncology, with a strong focus on thoracic oncology. His expertise includes designing and conducting clinical trials, with experience in Phase I, II, and III trials for advanced malignancies and targeted therapies. As the Coordinator of the Cancer Research and Innovation Unit at the Alexander Fleming Cancer Institute, he has honed his abilities in translational cancer research, contributing to numerous studies on innovative treatments for non-small cell lung cancer. His proficiency in biostatistics, clinical research methodology, and the use of patient-reported outcomes to improve therapy adherence further highlights his analytical and strategic thinking. Additionally, Dr. Enrico has received several prestigious awards for his scientific contributions and has successfully led collaborative projects funded by international grants. His deep understanding of oncological biomarkers and personalized medicine makes him a leading researcher in the oncology field.

Award And Recognition 

Dr. Diego H. Enrico, a distinguished medical oncologist, has garnered numerous accolades throughout his career, highlighting his significant contributions to oncology. He has received multiple “Best Scientific Work” awards at prestigious conferences such as the XLIII and XLII Argentine Association of Clinical Oncology Post-Chicago Meeting and Update (2023, 2022) for his groundbreaking research in targeted therapy for lung cancer and prostate cancer treatments. Dr. Enrico was also honored at the First National Congress on Oncology for his work on adverse effects in clinical trials (2020) and has received several best poster awards for his research on prognostic factors in liver metastases and breast cancer. Additionally, his work in clinical research ethics earned him recognition from the Jaime Roca Foundation with the Annual Bioethics Award in 2018. Dr. Enrico’s achievements underscore his expertise and dedication to advancing cancer treatment and clinical research globally.

Conclusion

Dr. Diego H. Enrico is a strong candidate for the Best Researcher Award, particularly due to his significant contributions to thoracic oncology research, his leadership in clinical innovation, and his consistent recognition through awards. Strengthening his international presence and expanding his research focus could further elevate his profile as a leading researcher in the global oncology community.

Publication Top Notes
  • “Manifestations of Exile and Diaspora in the Poetry of Abdullah al-Baradouni”
  • “The Educational Technology’s Impact on Youth Creativity and Innovation: A Case of Ha’il Region of Saudi Arabia”
    • Authors: Harman Preet Singh; Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2023
    • Source: Revista Amazonia Investiga
    • DOI: 10.34069/AI/2023.66.06.14
  • “The Impact of Globalization on Culture and Identity with Reference to Selected Works by Taha Hussein”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2022
    • Source: Addaiyan Journal of Arts, Humanities and Social Sciences
  • “City Literature in Abdu al-Aziz al-Makkali’s Poetry”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2021
    • Source: International Journal of Comparative Literature & Translation Studies
  • “Sociology and Literature: An Interdisciplinary Approach”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2020
    • Source: Journal of Liberal Arts and Humanities
  • “A Sociological Study of Some Selected Poems by Hatim Altai”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2020
    • Source: International Review of Humanities and Scientific Studies
  • “Literary Discourse and Human Rights in Martin Luther King’s Speech: I Have a Dream”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2019
    • Source: Studies in Literature and Language
  • “The Allegorical Structure in Animal Farm”
    • Authors: Mujahid Ahmed Mohammed Alwaqaa
    • Year: 2019
    • Source: Al-Yemenia University

 

Laura Bauman | Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Laura Bauman | Dentistry |Best Researcher Award

Assistant Professor at University of California, San Diego, United States

Dr. Laura Elizabeth Bauman, a pediatric gastroenterologist, excels in both clinical and academic settings, making her a strong candidate for the Best Researcher Award. She completed her fellowship at Cincinnati Children’s Medical Center and has been recognized with several prestigious awards, including the Arnold W. Strauss Award and the Young Investigator Travel Award. Dr. Bauman’s leadership roles include co-directing the Fecal Microbial Transplant Program and spearheading quality improvement initiatives at Rady Children’s Pediatric IBD Center. As a peer reviewer for top journals and an active member of professional organizations, she contributes significantly to the advancement of pediatric gastroenterology. Her dedication to service is evident in her work with the Crohn’s and Colitis Foundation and her leadership in fostering inclusivity at Rady Children’s Hospital. While further expanding her grant funding and publication portfolio would strengthen her profile, Dr. Bauman’s commitment to research and patient care makes her an outstanding researcher.

Profile:

Education:

Dr. Laura Elizabeth Bauman has a robust academic background, beginning with her Bachelor of Arts in Human Biology from Stanford University in 2007. She went on to earn her Medical Doctorate from the Geisel School of Medicine at Dartmouth in 2012, where she conducted research under Dr. Kari Rosenkranz. Following medical school, Dr. Bauman completed her pediatric internship and residency at the University of Utah from 2012 to 2015, with mentorship from Drs. Mark Deneau and M. Kyle Jensen. She then pursued specialized training through a Pediatric Gastroenterology, Hepatology, and Nutrition Fellowship at Cincinnati Children’s Medical Center from 2015 to 2018, working with Dr. Lee A. Denson. This extensive education, paired with her research and clinical training in leading institutions, has equipped Dr. Bauman with the expertise needed to excel in pediatric gastroenterology, with a focus on inflammatory bowel diseases and clinical research.

Professional Experience:

Dr. Laura Elizabeth Bauman’s professional experience is marked by her dedication to pediatric gastroenterology and her leadership in both clinical and academic settings. Since completing her fellowship at Cincinnati Children’s Medical Center in 2018, she has played pivotal roles at Rady Children’s Hospital in San Diego, where she co-directs the Fecal Microbial Transplant Program and leads quality improvement initiatives for pediatric inflammatory bowel disease (IBD) patients. Dr. Bauman is a key member of the hospital’s Gastroenterology Fellowship Clinical Competency Committee and collaborates on interdisciplinary projects to enhance patient care. She also serves on national committees, such as the Crohn’s and Colitis Foundation’s Pediatric Affairs Committee, contributing to the development of educational resources and clinical guidelines. A peer reviewer for top gastroenterology journals, Dr. Bauman remains actively involved in research, mentorship, and patient care, solidifying her reputation as a leader in pediatric gastroenterology.

Research Skills:

Dr. Laura Elizabeth Bauman possesses advanced research skills honed through years of focused academic and clinical inquiry in pediatric gastroenterology. Her expertise lies in inflammatory bowel diseases (IBD), where she has led and contributed to numerous research projects aimed at improving clinical outcomes for pediatric patients. Dr. Bauman’s ability to design, implement, and oversee research is demonstrated by her leadership in quality improvement initiatives, such as developing standardized care protocols for acute severe colitis at Rady Children’s Hospital. She is skilled in interdisciplinary collaboration, as shown by her work on the Fecal Microbial Transplant Program and her involvement in the creation of the Inpatient Acute Severe Ulcerative Colitis order set. Additionally, Dr. Bauman is an experienced peer reviewer for leading journals and has been recognized with awards, including the Arnold W. Strauss Award. Her capacity to blend clinical practice with research makes her an asset to the field of pediatric gastroenterology.

Award and Recognition:
Dr. Laura Elizabeth Bauman has received numerous awards and recognitions that highlight her excellence in research, clinical practice, and education. Notably, she was awarded the prestigious Arnold W. Strauss Award, a competitive $10,000 grant aimed at advancing clinical fellows’ research, specifically for her work on refractory ulcerative colitis. She also earned the Young Investigator Travel Award from the Crohn’s and Colitis Congress, recognizing her contributions to cutting-edge research in pediatric gastroenterology. In 2013, she was honored with the Golden Apple Award from the University of Utah’s Department of Pediatrics for her exceptional teaching and mentorship of medical students. Additionally, Dr. Bauman was selected as a candidate for the National Center for Leadership in Academic Medicine in 2023, a professional development program for junior faculty at UC San Diego. These accolades reflect Dr. Bauman’s commitment to advancing her field and her outstanding capabilities as both a researcher and educator.

Conclusion:

Dr. Laura Elizabeth Bauman is an outstanding candidate for the Research for Best Researcher Award, with a deep commitment to advancing pediatric gastroenterology through research, leadership, and service. While areas such as increasing her publication profile and securing larger grants could further strengthen her candidacy, her current achievements in clinical research and professional development make her a highly competitive nominee for this award.

Publication Top Notes:

  1. Mould DR, Upton RN, Wojciechowski J.
    Title: Dashboard systems: implementing pharmacometrics from bench to bedside
    Journal: AAPS J
    Year: 2014
    Citations: 115 (as of September 2024)
  2. Eser A, Primas C, Reinisch S, et al.
    Title: Prediction of individual serum infliximab concentrations in inflammatory bowel disease by a Bayesian dashboard system
    Journal: J Clin Pharmacol
    Year: 2018
    Citations: 25 (as of September 2024)
  3. Hyams J, Walters TD, Crandall W, et al.
    Title: Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension
    Journal: Curr Med Res Opin
    Year: 2011
    Citations: 229 (as of September 2024)
  4. Crombé V, Salleron J, Savoye G, et al.
    Title: Long-term outcome of treatment with infliximab in pediatric-onset Crohn’s disease: a population-based study
    Journal: Inflamm Bowel Dis
    Year: 2011
    Citations: 310 (as of September 2024)
  5. Wine E, Mack DR, Hyams J, et al.
    Title: Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis
    Journal: J Crohns Colitis
    Year: 2013
    Citations: 152 (as of September 2024)
  6. Hyams J, Crandall W, Kugathasan S, et al.; REACH Study Group
    Title: Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn’s disease in children
    Journal: Gastroenterology
    Year: 2007
    Citations: 945 (as of September 2024)
  7. Merras-Salmio L, Kolho KL.
    Title: Clinical use of infliximab trough levels and antibodies to infliximab in pediatric patients with inflammatory bowel disease
    Journal: J Pediatr Gastroenterol Nutr
    Year: 2017
    Citations: 62 (as of September 2024)
  8. Moore C, Corbett G, Moss AC.
    Title: Systematic review and meta-analysis: serum infliximab levels during maintenance therapy and outcomes in inflammatory bowel disease
    Journal: J Crohns Colitis
    Year: 2016
    Citations: 310 (as of September 2024)
  9. Frymoyer A, Hoekman DR, Piester TL, et al.
    Title: Application of population pharmacokinetic modeling for individualized infliximab dosing strategies in Crohn disease
    Journal: J Pediatr Gastroenterol Nutr
    Year: 2017
    Citations: 63 (as of September 2024)
  10. Vande Casteele N, Khanna R, Levesque BG, et al.
    Title: The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn’s disease
    Journal: Gut
    Year: 2015
    Citations: 725 (as of September 2024)

 

 

Lawrence Lopes | Dental Materials | Best Researcher Award

Posted on by ScienceFather

Prof. Lawrence Lopes | Dental Materials | Best Researcher Award 

Professor at UFG/Faculty of Dentistry, Brazil.

Lawrence Gonzaga Lopes is a distinguished Professor of Dentistry at the Federal University of Goiás (UFG), Brazil, specializing in esthetic restorative materials. He holds both a Master’s and Doctorate in Dentistry from the University of São Paulo. His research encompasses the evaluation of polymerization and contraction stresses in restorative materials, with extensive contributions to the field through 81 publications in national and international journals and 4 book chapters. Lopes has supervised 10 Master’s and 8 Doctoral theses and is recognized for his impact with multiple awards, including first place at the International Congress of Goiás in 2019. His leadership roles include serving as Director of the Academic Management Center at UFG and various positions in academic committees. His research significantly impacts dental materials performance and clinical applications, making him a leading figure in his field.

Profile

Education

Lawrence Gonzaga Lopes holds a distinguished educational background in the field of Dentistry. He earned his Doctorate in Dental Sciences from the Faculdade de Odontologia de Bauru at the Universidade de São Paulo (USP) in 2003, focusing on the evaluation of polymerization shrinkage and stress in different curing systems and aesthetic restorative materials. Prior to this, he completed his Master’s degree in Dentistry at the same institution in 2000, where his research centered on marginal infiltration related to cavity configuration and aesthetic restorative materials. His academic journey began with a specialization in Dentistry from the Universidade Federal de Uberlândia in 1998 and an undergraduate degree in Dentistry from the same institution in 1996. This extensive education has laid a solid foundation for his career as a leading academic and researcher in the field of dental materials and restorative techniques.

Professional Experience

Lawrence Gonzaga Lopes, a distinguished professional in the field of Odontology, currently serves as a Professor at the Federal University of Goiás (UFG) in Brazil. He has a rich background in dental materials and clinical dentistry, holding both a Master’s and Doctorate degree from the Faculty of Dentistry of Bauru at the University of São Paulo. Since 2005, Lopes has been a full professor at UFG, where he contributes to both undergraduate and postgraduate programs. His professional journey includes significant roles in various institutions, such as serving as a coordinator and vice-director at UFG and as a faculty member at the University Catholic of Brasília. His extensive experience also encompasses directorships in academic administration and significant contributions to research, focusing on dental materials and clinical practices. Lopes has been recognized for his academic leadership and impactful research in the field of dentistry.

 Research Interest

Lawrence Gonzaga Lopes is a distinguished researcher with a focus on advanced dental materials and restorative dentistry. His research primarily addresses the performance and optimization of dental materials, including polymerization processes, contraction stresses, and marginal infiltration of aesthetic restorative materials. He is deeply involved in evaluating the physical, mechanical, chemical, and biological properties of these materials to enhance their clinical efficacy and longevity. His work also explores innovative solutions for clinical challenges in dentistry, aiming to improve patient outcomes and dental practices. Lopes’ research contributes to the development of more effective and durable dental restorative systems, significantly impacting the field of dental materials science. Through his extensive research and numerous publications, Lopes has made significant strides in advancing the understanding and application of dental materials, benefiting both the scientific community and clinical practices in dentistry.

Research Skills

Lawrence Gonzaga Lopes demonstrates exceptional research skills in the field of Dentistry, particularly within the domain of restorative and aesthetic materials. His extensive expertise encompasses the evaluation of polymerization shrinkage, the performance of dental materials, and the investigation of adhesive bonding strength. Dr. Lopes’s proficiency extends to advanced methodologies in material science, including nanotechnology and polymer chemistry, which he applies to enhance the efficacy and durability of dental restorations. His research involves both fundamental studies and applied research, such as the development and optimization of composite resins and the assessment of their clinical performance. He is adept at employing a range of analytical techniques, including microstructural analysis and mechanical testing, to ensure comprehensive evaluation of materials. His contributions are well-documented in numerous high-impact publications, reflecting his commitment to advancing dental material science and his role as a leading researcher in the field.

Awards and Recognition

Lopes has received numerous accolades for his contributions to dental research and education. Notable awards include the Comenda Professor Colemar Natal e Silva for his services to higher education and several first-place awards at dental congresses for his scientific presentations. His recognition by various academic and professional bodies underscores his impact and excellence in the field.

Conclusion

Lawrence Gonzaga Lopes is a leading figure in the field of restorative dentistry, with significant contributions to dental materials research and clinical applications. His extensive publication record, collaborative efforts, and numerous awards highlight his dedication and impact. While his research primarily focuses on dental materials and restorative techniques, its applications and implications extend to broader aspects of dental practice and environmental sustainability. Lopes’ work stands as a testament to his commitment to advancing the field and improving patient outcomes through innovative research and applied science.

Publications Top Notes
  1. Characterization of experimental resin composites with cholesteryl methacrylate organic matrix – Part 2
    • Authors: J.D.S. Silva, L.N. de Almeida, A.S. Machado, R. Menegatti, L.G. Lopes
    • Year: 2024
  2. Influence of the Flowable Resin Layer on Bond Strength Between Resin Cement and a Universal Adhesive Applied in the Immediate Dentin-sealing Technique
    • Authors: J. Batista, M.M. Leite, M.F. Sabag, L.G. Lopes, É.M. Torres
    • Year: 2022
    • Citations: 1
  3. Attitudes of dentists toward maintaining, repairing, or replacing direct composite resin restorations
    • Authors: C.O. Silva, L.G. Lopes, É.M. Torres, A.A. Carvalho, J.B. Souza
    • Year: 2022
    • Citations: 1
  4. Influence of different application protocols of universal adhesive system on the clinical behavior of Class I and II restorations of composite resin – A randomized and double-blind controlled clinical trial
    • Authors: A.A. Carvalho, M.M. Leite, J.K.M. Zago, É.M.D. Torres, L.G. Lopes
    • Year: 2019
    • Citations: 17
  5. Resin Cement: Correspondence with Try-In Paste and Influence on the Immediate Final Color of Veneers
    • Authors: E.C. Vaz, M.M. Vaz, É.M. de Torres, T.D.J.E. Barata, L.G. Lopes
    • Year: 2019
    • Citations: 18
  6. Immediate dentin sealing with self-etch dentin bonding agent for indirect restoration
    • Authors: M.M. Leite, D.R. de Souza, M.A. Carvalho, L.G. Lopes, É.M. de Torres
    • Year: 2017
    • Citations: 2
  7. Ozone gas effect on mineral content of dentin exposed to Streptococcus mutans biofilm: An energy-dispersive X-ray evaluation
    • Authors: R.M. Chaves, C. Estrela, P.C. Cardoso, A.P.R. Magalhães, L.G. Lopes
    • Year: 2017
    • Citations: 7
  8. Inflammatory response of human dental pulp to at-home and in-office tooth bleaching
    • Authors: M.M. Vaz, L.G. Lopes, P.C. Cardoso, É.M. Torres, C. Estrela
    • Year: 2016
    • Citations: 48
  9. Influence of curing mode of resin luting cements on bond strength to dentin
    • Authors: A.A. Carvalho, A. Stefani, W.F.S. Barbosa, L.G. Lopes, M. Giannini
    • Year: 2016
    • Citations: 1
  10. Silver nanoparticles in resin luting cements: Antibacterial and physiochemical properties
    • Authors: A.-P.-R. Magalhães, F.-C.-L. Moreira, D.-R.-S. Alves, A.-F. Bakuzis, L.-G. Lopes
    • Year: 2016
    • Citations: 27